Xiaoming Zhang
Fondateur chez Theron Pharmaceuticals, Inc.
Profil
Xiaoming Zhang is the founder and director at Theron Pharmaceuticals, Inc., which was founded in 2008.
Dr. Zhang also held former positions as a director of medical chemistry at Millennium Pharmaceuticals, Inc., senior director at CoMentis, Inc., director of medical chemistry at Portola Medical, Inc., senior vice president of CMC at Menlo Therapeutics, Inc., principal at ARYx Therapeutics, Inc. (Delaware), and principal at Roche Bioscience.
Dr. Zhang also served as a venture partner at Velocity Pharmaceutical Development LLC.
From 2015 to 2020, Dr. Zhang was the senior vice president at VYNE Therapeutics, Inc. and from 2020 to 2022, Dr. Zhang was the chief technical officer at Vincerx Pharma, Inc. Dr. Zhang obtained a doctorate degree from the University of Maryland.
Postes actifs de Xiaoming Zhang
| Sociétés | Poste | Début |
|---|---|---|
Theron Pharmaceuticals, Inc.
 Theron Pharmaceuticals, Inc. BiotechnologyHealth Technology Theron Pharmaceuticals, Inc. provides treatments for COPD and asthma. It is a biotechnology company, develops long acting M3 muscarinic antagonist (LAMA) products for the treatment of chronic respiratory diseases. The firm’s product TRN-157, a preclinical development therapy focuses on treating chronic obstructive pulmonary disease and severe asthma. The company was founded by M. Venkatraman, Xiaoming Zhang and Jurg Pfister in 2008 and is headquartered in Sunnyvale, CA. | Fondateur | 17/05/2011 |
Anciens postes connus de Xiaoming Zhang
| Sociétés | Poste | Fin |
|---|---|---|
| VINCERX PHARMA, INC. | Directeur Technique/Scientifique/R&D | 01/08/2022 |
| VYNE THERAPEUTICS INC. | Corporate Officer/Principal | 01/03/2020 |
| VYNE THERAPEUTICS INC. | Corporate Officer/Principal | - |
Velocity Pharmaceutical Development LLC
 Velocity Pharmaceutical Development LLC Drugstore ChainsRetail Trade Velocity Pharmaceutical Development LLC develops pharmaceutical drugs. It identifies drug candidates, target markets and designing and managing outsourced clinical trials. The firm seeks to acquire promising drug candidates, generally within a year of their entering human clinical trials or after initial human clinical data have been generated. The company was founded by David Collier, Ed Schnipper, Jim Larrick and Andy Perlman in 2011 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Roche Bioscience
 Roche Bioscience Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche Bioscience is a company that discovers and develops prescription drugs. The company is based in Palo Alto, CA. | Corporate Officer/Principal | - |
Formation de Xiaoming Zhang
| University of Maryland | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| VYNE THERAPEUTICS INC. | Health Technology |
| VINCERX PHARMA, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Theron Pharmaceuticals, Inc.
Theron Pharmaceuticals, Inc. BiotechnologyHealth Technology Theron Pharmaceuticals, Inc. provides treatments for COPD and asthma. It is a biotechnology company, develops long acting M3 muscarinic antagonist (LAMA) products for the treatment of chronic respiratory diseases. The firm’s product TRN-157, a preclinical development therapy focuses on treating chronic obstructive pulmonary disease and severe asthma. The company was founded by M. Venkatraman, Xiaoming Zhang and Jurg Pfister in 2008 and is headquartered in Sunnyvale, CA. | Health Technology |
Menlo Therapeutics, Inc.
 Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Menlo Therapeutics Inc. operates as biopharmaceutical company which is focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. The company was founded by Ed F. Schnipper in October, 2011 and is headquartered in Bridgewater, CA. | Health Technology |
CoMentis, Inc.
 CoMentis, Inc. Pharmaceuticals: MajorHealth Technology CoMentis, Inc. focuses on developing drugs to treat various central nervous system disorders. Its research and development spectrum include BACE inhibitors and modulators of the a7 nicotinic acetylcholine receptor (NAChR). The company was founded by John P. Cooke and Muralitharan Kengatharan in 2006 and is headquartered in South San Francisco, CA. | Health Technology |
ARYx Therapeutics, Inc. (Delaware)
 ARYx Therapeutics, Inc. (Delaware) Pharmaceuticals: MajorHealth Technology Part of ARYx Therapeutics, Inc., ARYx Therapeutics, Inc. (Delaware) discovers and develops drugs. The company is based in Dover, DE. ARYx Therapeutics, Inc. (Delaware was acquired by ARYx Therapeutics, Inc. on August 31, 2007. | Health Technology |
Roche Bioscience
Roche Bioscience Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche Bioscience is a company that discovers and develops prescription drugs. The company is based in Palo Alto, CA. | Health Technology |
Velocity Pharmaceutical Development LLC
Velocity Pharmaceutical Development LLC Drugstore ChainsRetail Trade Velocity Pharmaceutical Development LLC develops pharmaceutical drugs. It identifies drug candidates, target markets and designing and managing outsourced clinical trials. The firm seeks to acquire promising drug candidates, generally within a year of their entering human clinical trials or after initial human clinical data have been generated. The company was founded by David Collier, Ed Schnipper, Jim Larrick and Andy Perlman in 2011 and is headquartered in South San Francisco, CA. | Retail Trade |
Portola Medical, Inc.
 Portola Medical, Inc. Medical SpecialtiesHealth Technology Part of Huiheng Medical, Inc., Portola Medical, Inc. manufactures and distributes large radiation oncology medical equipment used for the treatment of cancer and tumors. Portola Medical was acquired by Huiheng Medical, Inc. on June 07, 2010 for $0.26 million. | Health Technology |